Silvia Rasi

6.7k total citations
39 papers, 1.8k citations indexed

About

Silvia Rasi is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Silvia Rasi has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 15 papers in Pathology and Forensic Medicine and 11 papers in Molecular Biology. Recurrent topics in Silvia Rasi's work include Chronic Lymphocytic Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Silvia Rasi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Silvia Rasi collaborates with scholars based in Italy, Switzerland and United States. Silvia Rasi's co-authors include Gianluca Gaïdano, Davide Rossi, Valeria Spina, Clara Deambrogi, Lorenzo De Paoli, Valter Gattei, Daniela Capello, Pier Luigi Luisi, Fabio Mavelli and Michaela Cerri and has published in prestigious journals such as Blood, The Journal of Physical Chemistry B and Clinical Cancer Research.

In The Last Decade

Silvia Rasi

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Rasi Italy 20 1.0k 995 520 504 382 39 1.8k
Nakhle S. Saba United States 17 619 0.6× 582 0.6× 634 1.2× 291 0.6× 361 0.9× 65 1.6k
Julia Parrish-Novak United States 13 177 0.2× 95 0.1× 312 0.6× 1.1k 2.2× 309 0.8× 14 1.8k
Rajni Sinha United States 18 864 0.8× 1.3k 1.3× 574 1.1× 359 0.7× 1.0k 2.6× 61 2.5k
Bradley T. Messmer United States 16 1.2k 1.1× 749 0.8× 574 1.1× 1.2k 2.3× 222 0.6× 41 2.1k
Per‐Ola Andersson Sweden 23 425 0.4× 671 0.7× 511 1.0× 422 0.8× 524 1.4× 72 2.1k
Douglas C. Saffran United States 17 1.1k 1.1× 217 0.2× 890 1.7× 1.9k 3.8× 509 1.3× 33 3.2k
Ruth R. French United Kingdom 32 1.0k 1.0× 1.1k 1.1× 1.1k 2.1× 2.7k 5.3× 1.5k 3.8× 58 4.5k
Raymund Buhmann Germany 17 354 0.3× 257 0.3× 724 1.4× 818 1.6× 303 0.8× 36 1.6k
Paul G. Abrams United States 21 291 0.3× 301 0.3× 434 0.8× 452 0.9× 519 1.4× 50 1.8k
Davide Genini United States 19 324 0.3× 161 0.2× 799 1.5× 312 0.6× 442 1.2× 24 1.7k

Countries citing papers authored by Silvia Rasi

Since Specialization
Citations

This map shows the geographic impact of Silvia Rasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Rasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Rasi more than expected).

Fields of papers citing papers by Silvia Rasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Rasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Rasi. The network helps show where Silvia Rasi may publish in the future.

Co-authorship network of co-authors of Silvia Rasi

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Rasi. A scholar is included among the top collaborators of Silvia Rasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Rasi. Silvia Rasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maher, Nawar, et al.. (2025). Unraveling the Epigenetic Landscape of Mature B Cell Neoplasia: Mechanisms, Biomarkers, and Therapeutic Opportunities. International Journal of Molecular Sciences. 26(17). 8132–8132.
2.
Rossi, Davide, Fary Diop, Elisa Spaccarotella, et al.. (2017). Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 129(14). 1947–1957. 181 indexed citations
3.
Rossi, Davide, Hossein Khiabanian, Valeria Spina, et al.. (2014). Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 123(14). 2139–2147. 228 indexed citations
4.
Rossi, Davide, Silvia Rasi, Valeria Spina, et al.. (2012). The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1. PubMed. 1(S2). S26–S28. 2 indexed citations
5.
Rossi, Davide, Valeria Spina, Francesco Forconi, et al.. (2011). Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis. International Journal of Cancer. 130(12). 3006–3010. 25 indexed citations
6.
Giudice, Ilaria Del, Davide Rossi, Sabina Chiaretti, et al.. (2011). NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica. 97(3). 437–441. 122 indexed citations
7.
Rasi, Silvia & Gianluca Gaïdano. (2011). IRF4 (interferon regulatory factor 4). Atlas of Genetics and Cytogenetics in Oncology and Haematology.
8.
Rasi, Silvia, Valeria Spina, Alessio Bruscaggin, et al.. (2010). A variant of theLRP4gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology. 152(3). 284–294. 29 indexed citations
9.
Rossi, Davide, Michaela Cerri, Clara Deambrogi, et al.. (2009). The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness. Clinical Cancer Research. 15(3). 995–1004. 206 indexed citations
10.
Scandurra, Marta, Davide Rossi, Clara Deambrogi, et al.. (2009). Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas. Hematological Oncology. 28(2). 62–67. 37 indexed citations
11.
Rossi, Davide, Elisa Sozzi, Lorenzo De Paoli, et al.. (2009). The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. British Journal of Haematology. 146(1). 64–75. 103 indexed citations
12.
Capello, Daniela, Silvia Rasi, Pierluigi Oreste, et al.. (2009). Molecular characterization of post‐transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. The Journal of Pathology. 218(4). 478–486. 30 indexed citations
13.
Rossi, Davide, Silvia Rasi, Silvia Franceschetti, et al.. (2009). Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21. Leukemia. 23(6). 1118–1126. 90 indexed citations
14.
Rossi, Davide, Michaela Cerri, Daniela Capello, et al.. (2008). Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology. 142(2). 202–215. 164 indexed citations
15.
Capello, Daniela, Clara Deambrogi, Davide Rossi, et al.. (2008). Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia‐negative chronic myeloproliferative disorders. British Journal of Haematology. 141(4). 504–511. 48 indexed citations
16.
Rossi, Davide, Antonella Zucchetto, Francesca Maria Rossi, et al.. (2008). CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica. 93(10). 1575–1579. 56 indexed citations
17.
Capello, Daniela, Maurizio Martini, Annunziata Gloghini, et al.. (2008). Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica. 93(8). 1178–1185. 18 indexed citations
18.
Kammer, Andreas R., et al.. (2007). A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses. Vaccine. 25(41). 7065–7074. 46 indexed citations
19.
Ferreri, Carla, Andrea Barbieri, Laura Zambonin, et al.. (2005). Comparison of Phosphatidylcholine Vesicle Properties Related to Geometrical Isomerism†. Photochemistry and Photobiology. 82(1). 274–274. 19 indexed citations
20.
Esposito, Elisabetta, et al.. (2003). Lipid-based supramolecular systems for topical application: A preformulatory study. PubMed. 5(4). 62–76. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nakhle S. Saba Breakdown of academic impact, for papers by Julia Parrish-Novak Breakdown of academic impact, for papers by Rajni Sinha Breakdown of academic impact, for papers by Bradley T. Messmer Breakdown of academic impact, for papers by Per‐Ola Andersson Breakdown of academic impact, for papers by Douglas C. Saffran Breakdown of academic impact, for papers by Ruth R. French Breakdown of academic impact, for papers by Raymund Buhmann Breakdown of academic impact, for papers by Paul G. Abrams Breakdown of academic impact, for papers by Davide Genini
Rankless by CCL
2026